Grifols Diagnostic Solutions
UEI: R4N2Y6E9D6H7
• CAGE: 7AJ96
Overview
Parent Awardee
Company Description
Grifols, global healthcare leader in producing plasma derived medicines and other innovative biopharmaceutical solutions, is dedicated to improving the health and well-being of patients.
Name
Grifols Diagnostic Solutions
Headquarters
Emeryville, CA
United States
United States
Most Recent Award
Nov. 1, 2026
Calculating
Grifols Diagnostic Solutions is a federal contract recipient (UEI R4N2Y6E9D6H7; CAGE 7AJ96). It is headquartered in Emeryville, CA. Its primary registered NAICS is 325413: In-Vitro Diagnostic Substance Manufacturing. The international organization was founded in January 2014 and federally registered in October 2014.
Federal Award Analysis
Grifols Diagnostic Solutions federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
GRIFOLS DIAGNOSTIC SOLUTIONS INC.
UEI
R4N2Y6E9D6H7
CAGE Code
7AJ96
Primary NAICS
SBA Certifications
None
Self Certifications
None
Entity Structure
International Organization
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 1, 2014
Initial Registration
Oct. 21, 2014
Last Registration
Aug. 26, 2026
Registration Activation
Aug. 26, 2026
Registration Expiration
Aug. 21, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
NC
Country of Incorporation
USA
Employees
>1500
Reported NAICS
Accepts Credit Cards
Yes
People
Vendor contacts at Grifols Diagnostic Solutions
GSA Schedules and Price Lists
- Grifols Diagnostic Solutions
- PoP: 4/29/20 - 4/30/25 (Ended)
- Type: Critical Analyzers, Laboratory, Cost-Per-Test (FSS 66 III)
- Obligated: $463,082
- View | Download
- Grifols Diagnostic Solutions
- PoP: 3/14/20 - 3/14/25 (Ended)
- Type: Invitro Diagnostics, Reagents, Test Kits and Test Sets (FSS 65 VII)
- Obligated: $307,848
- View | Download